Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences (Nasdaq: OACC) is a blank-check company targeting the life sciences and healthcare sectors, sponsored by an affiliate of Oaktree Capital Management, L.P., the Los Angeles-based alternative investment firm with a global footprint across credit and equity strategies. The vehicle is the third SPAC launched under the Oaktree Acquisition Corp. franchise, reflecting the sponsor's sustained presence in the blank-check market. The company filed an 8-K with the Securities and Exchange Commission on October 29, 2025, adding to its active public disclosure record. For comprehensive filing history, deal timelines, and SPAC comparables on OACC, sign up for full data at SpacDesk.